Standard Biotools (LAB) EPS (Basic) Growth (3y) (2013 - 2026)
Standard Biotools (LAB) EPS (Basic) Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.20 Bn | 193.60 Bn | 7.27 Bn | -12.28% |
| 2 | Stryker | 127.66 Bn | 124.19 Bn | 4.50 Bn | 19.63% |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 3.18% |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 50.64% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -6.23% |
| 6 | Dexcom | 34.37 Bn | 32.42 Bn | 830.00 Mn | 29.56% |
| 7 | GE HealthCare Technologies | 33.89 Bn | 31.78 Bn | 2.18 Bn | 11.31% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 1,801.39% |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn | 17.98% |
| 10 | Standard Biotools | 253.06 Mn | -223.66 Mn | 10.54 Mn | 31.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 60.46% |
| Mar 31, 2026 | 54.86% |
| Dec 31, 2025 | -26.05% |
| Sep 30, 2025 | 37.59% |
| Jun 30, 2025 | 61.54% |
| Mar 31, 2025 | 80.77% |
| Sep 30, 2024 | 55.13% |
| Jun 30, 2024 | 47.66% |
| Mar 31, 2024 | 24.27% |
| Dec 31, 2023 | 39.45% |
| Sep 30, 2023 | -47.21% |
| Jun 30, 2023 | -5.68% |
| Mar 31, 2023 | 2.03% |
| Dec 31, 2022 | 130.83% |
| Sep 30, 2022 | -26.21% |
| Jun 30, 2022 | -60.14% |
| Mar 31, 2022 | -31.46% |
| Sep 30, 2021 | -20.26% |
| Jun 30, 2021 | -4.60% |
| Mar 31, 2021 | 9.60% |